{"id":18212,"date":"2014-07-09T10:30:00","date_gmt":"2014-07-09T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/antitrust-ue-ammenda-per-4277-mln-a-servier-e-5-produttori-per-cartello-2\/"},"modified":"2014-07-09T10:30:00","modified_gmt":"2014-07-09T08:30:00","slug":"antitrust-ue-ammenda-per-4277-mln-a-servier-e-5-produttori-per-cartello-2","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/antitrust-ue-ammenda-per-4277-mln-a-servier-e-5-produttori-per-cartello-2\/","title":{"rendered":"EU Antitrust: fine of 427.7 million to Servier and 5 producers for cartel"},"content":{"rendered":"

Objective to defend perindropil from price competition (Il Sole 24 Ore Radiocor) <\/span><\/span><\/p>\n

<\/span><\/p>\n

\u2013 Brussels, 09 Jul \u2013 The EU Commission has imposed fines totaling 427.7 million euros on the French pharmaceutical company Servier and five manufacturers of generic drugs: Niche\/Unichem, Matrix (which is part of the Mylan group), Teva, Krka and Lupin. Reason: They concluded a series of illegal deals to protect Servier's best-selling blood pressure drug perindopril from price competition from other generics in the EU.<\/span><\/span><\/p>\n

<\/span><\/p>\n

ap<\/p>\n

<\/span><\/p>\n

(RADIOCOR) 09-07-14 <\/p>\n

<\/span><\/p>\n

Fine of 331 million to a French pharmaceutical company for blocking the entry of generics into the EU<\/p>\n

<\/span><\/p>\n

Bruselas sanctions with 97 millones a otros 5 fabricantes de gen\u00e9ricos<\/span><\/span><\/p>\n

<\/span><\/p>\n

Servier agreed with them to avoid competencies on your drug for hypertension<\/span><\/span><\/p>\n

<\/span><\/p>\n

09.07.2014 AGENCIES rtve.es<\/a> <\/p>\n

<\/span><\/p>\n

The European Commission has imposed a fine of 331 million euros on the French farmac\u00e9utica servicing pactar acuerdos to prevent the entry into the market of a more cheap version of a cardiovascular drug. Cinco manufacturers of generic medicines that are accessed<\/p>","protected":false},"excerpt":{"rendered":"

Obiettivo difendere il perindropil da concorrenza prezzi (Il Sole 24 Ore Radiocor) – Bruxelles, 09 lug – La Commissione Ue ha inflitto ammende per un totale di 427,7 mln di euro all’impresa farmaceutica francese Servier e a cinque produttori di farmaci generici: Niche\/Unichem, Matrix (che fa parte del gruppo Mylan), Teva, Krka et Lupin. Motivo: …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-18212","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=18212"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18212\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=18212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=18212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=18212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}